Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
25 March, 2017 09:35 IST
Aurobindo Pharma gets USFDA nod for anti-cough tablets
Source: IRIS | 21 Mar, 2017, 09.14AM
Comments  |  Post Comment

Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets, 600/30 mg and 1200/60mg (OTC). Aurobindo's Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets are the AB rated generic equivalent of Reckitt Benckiser's Mucinex DM tablets. The product will be launched in Q1FY18.

Guaifenesin and Dextromethorphan Hydrobromide extended-release tablets helps loosen mucus and phlegm, and thin out bronchial secretions, making coughs more productive. The approved product has an estimated market size of US$ 235 million for the twelve months ending December 2016 according to IRI database.

This is the 106 th ANDA (including 21 tentative approvals) approved out of Unit VII formulation facility in Hyderabad, India used for manufacturing oral products. Aurobindo now has a total of 311 ANDA approvals (272 Final approvals including 16 from Aurolife Pharma LLC and 39 tentative approvals) from USFDA.

Shares of the company gained Rs 1.7, or 0.24%, to trade at Rs 704.90. The total volume of shares traded was 0 at the BSE (9.01 a.m., Tuesday).



Aurobindo Pharma Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
RCap completes transfer of commercial finance biz to subsidiary - 24-Mar-2017 18:46
TCS, LIBA to launch management program on Business Analytics - 24-Mar-2017 11:56
Asian Oilfield wins LoA for contract worth Rs 1.08 bn - 24-Mar-2017 11:50
Asian Oilfield wins LoA for contract worth Rs 1.08 bn - 24-Mar-2017 11:50
NTPC plans to achieve 32 GW installed capacity via renewable sources by 2032 - 24-Mar-2017 10:47
RCF issues commercial paper worth Rs 1.50 bn - 24-Mar-2017 10:21
Ujaas Energy bags order from Indraprastha Power - 24-Mar-2017 09:29
NHPC inks purchase pacts with Tata Power - 24-Mar-2017 09:13
Siemens bags RE order worth Rs 1.87 bn - 24-Mar-2017 09:09
Bharti Airtel to acquire Tikona Networks' 4G biz for Rs 16 bn - 24-Mar-2017 08:52
Lupin receives USFDA nod for generic inhalation solution - 23-Mar-2017 16:00
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer